Form 4: Cassava Sciences Director Robert Gussin Acquires 15,000 Stock Options

Director Robert Gussin acquired 15,000 stock options in Cassava Sciences Inc. on May 9, 2024, as part of the Non-employee Director Compensation Program.

Summary

• Robert Z. Gussin, a director of Cassava Sciences Inc., filed a Form 4 to report changes in beneficial ownership.
• On May 9, 2024, Gussin acquired 15,000 stock options with an exercise price of $21.11.
• These options were granted pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023.
• The stock options vest over a one-year period at a rate of 1/12 per month and expire on May 9, 2034.
• Following the transaction, Gussin directly owns 15,000 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The grant of stock options is a routine part of director compensation and signals confidence in the company's future.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and contribution to the company over the next year.

Future Outlook

The document does not contain specific forward-looking statements, but the stock option grant suggests an expectation of continued service from the director.

Industry Context

Stock option grants are a common form of compensation for directors, aligning their interests with the long-term performance of the company. This is a standard practice in the biotechnology industry to incentivize board members.

Comparison to Industry Standards

• Stock option grants to board members are a common practice across the biotechnology industry.
• Companies like Biogen and Amgen also use stock options as part of their director compensation packages.
• The vesting schedule of one year is fairly standard, aligning with typical industry practices for director compensation.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term value.
• The vesting schedule encourages the director's continued service and contribution to the company.

Key Dates